Trevena, Inc. (TRVN)
OTCMKTS · Delayed Price · Currency is USD
0.0110
0.00 (0.00%)
Jan 21, 2026, 9:30 AM EST
Trevena Market Cap
Trevena has a market cap or net worth of $10.64 thousand as of January 23, 2026. Its market cap has decreased by -99.70% in one year.
Market Cap
10.64K
Enterprise Value
24.11M
Revenue
546.00K
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.01
Market Cap Chart
Since January 31, 2014, Trevena's market cap has decreased from 167.27M to 10.64K, a decrease of -99.99%. That is a compound annual growth rate of -55.35%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 22, 2026 | 10.64K | -7.49% |
| Dec 31, 2025 | 11.51K | -99.11% |
| Dec 31, 2024 | 1.30M | -88.18% |
| Dec 29, 2023 | 10.96M | -0.67% |
| Dec 30, 2022 | 11.03M | -88.49% |
| Dec 31, 2021 | 95.83M | -71.48% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Virpax Pharmaceuticals | 13.79K |
| Vaxxinity | 12.68K |
| PaxMedica | 12.63K |
| Scorpius Holdings | 12.23K |
| ObsEva | 11.72K |
| GeneLink | 10.60K |
| Biostax | 10.52K |
| Entia Biosciences | 10.22K |